SI-BONE Director Jeffrey Dunn Executes Non-Discretionary Share Transactions
SI-BONE, Inc. (NASDAQ: SIBN) director Jeffrey W. Dunn engaged in a series of structured stock transactions in early June 2026, primarily driven by the vesting of restricted stock units and subsequent tax withholding requirements. The medical device manufacturer reported its first-quarter 2026 financial results, showing a narrower net loss than anti…